| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CCO | EVP, Chief Commercial Officer | Director
1 company
Poyhonen John is a President &CCO at HRTX. Recent filings cover 3 purchases and 0 sales. Those positions are worth an estimated $134K at current prices.
Poyhonen John's largest disclosed position is in HRTX as President &CCO, worth about $134K. Net of sales, the recent Form 4 record there shows accumulation of 18,143 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2019 | HRTX Heron Therapeutics, Inc. /de/ | EVP, Chief Commercial Officer | Buy | 5,143 | $17.50 | $90,002.50 | +39.6% | |
| May 22, 2019 | HRTX Heron Therapeutics, Inc. /de/ | Director | Buy | 3,000 | $17.55 | $52,650.00 | +30.0% | |
| Jan 19, 2017 | HRTX Heron Therapeutics, Inc. /de/ | Director | Buy | 10,000 | $12.20 | $122,000.00 | New |